Qisda Corporation

Informe acción TWSE:2352

Capitalización de mercado: NT$39.3b

Qisda Resultados de beneficios anteriores

Pasado controles de criterios 1/6

Los beneficios de Qisda han disminuido a una tasa media anual de -36%, mientras que en la industria Tech los beneficios crecieron en un 4.2% anualmente. Los ingresos han ido disminuyendo a una tasa media de 2.4% al año. La rentabilidad financiera de Qisda es de 1.9%, y sus márgenes netos son de 0.5%.

Información clave

-35.97%

Tasa de crecimiento de los beneficios

-36.50%

Tasa de crecimiento del BPA

Crecimiento de la industria Tech 14.00%
Tasa de crecimiento de los ingresos-2.42%
Rentabilidad financiera1.94%
Margen neto0.47%
Última actualización de beneficios31 Mar 2026

Actualizaciones de resultados anteriores recientes

Recent updates

Actualización del análisis Apr 02

2352: Steady Fair Value And Refined Assumptions Will Support Future Upside

Analysts have kept Qisda's fair value view broadly unchanged, with only very small tweaks to inputs like the discount rate and future P/E. These adjustments feed into a steady NT$36.73 price target that signals continued confidence in their existing valuation framework.
Actualización del análisis Mar 19

2352: Higher Profitability Assumptions And Steady Fair Value Will Support Future Upside

Analysts kept their NT$36.73 price target for Qisda unchanged, citing slightly adjusted assumptions for discount rate, revenue growth, profit margin, and future P/E that effectively offset one another in their updated model. Valuation Changes Fair Value: NT$36.73 is unchanged in the updated model, indicating no revision to the overall equity value per share.
Actualización del análisis Mar 04

2352: Stable Assumptions And Slightly Higher P E Will Support A Higher Share Price

Analysts have made a small upward adjustment to their Qisda price target to reflect updated assumptions around the discount rate and future P/E. They have kept their fair value estimate broadly unchanged at about NT$36.73 per share.
Actualización del análisis Feb 18

2352: Stable Assumptions And Lower Discount Rate Will Support A Higher Share Price

Analysts have modestly adjusted their price target on Qisda to NT$36.73, reflecting fine tuning of assumptions such as a slightly lower discount rate, stable revenue growth and profit margin expectations, and a marginally revised future P/E multiple. Valuation Changes Fair Value: NT$36.73 is unchanged, indicating the updated inputs leave the core valuation estimate essentially the same.
Nuevo análisis Feb 06

AI Hardware Delays And Medical Regulatory Risks Will Eventually Support A Gradual Turnaround

Catalysts About Qisda Qisda is a diversified electronics and solutions group with businesses spanning information technology hardware, medical equipment and services, smart business solutions and networking and communications. What are the underlying business or industry changes driving this perspective?
Actualización del análisis Feb 03

2352: Steady Assumptions And Higher Required Return Will Support A Higher Share Price

Analysts have kept their price target for Qisda steady at US$36.73. Modest tweaks to inputs such as the discount rate and assumed future P/E suggest only fine tuning rather than a shift in their underlying outlook.
Actualización del análisis Jan 19

2352: Stable Long Term Assumptions Will Support A Higher Future Share Price

Analysts have kept their Qisda fair value estimate steady at about $36.73 per share, with only very small model updates to the discount rate, revenue growth, profit margin and future P/E assumptions guiding this unchanged price target. Valuation Changes Fair Value: The intrinsic value estimate is unchanged at about NT$36.73 per share.
Actualización del análisis Jan 05

2352: Stable Assumptions And Earnings Outlook Will Support Stronger Share Price

Analysts have kept their price target for Qisda broadly in line with prior estimates. The changes reflect only very small model tweaks around discount rate, revenue growth, profit margin and future P/E assumptions, rather than any major change in their view of the stock.
Actualización del análisis Dec 14

2352: Stable Earnings Outlook Should Support Stronger Future Share Price Performance

Analysts have raised their price target on Qisda modestly to reflect slightly lower discount rates and a marginally improved long term earnings outlook, while keeping fair value estimates effectively unchanged at around $36.73 per share. Valuation Changes Fair Value Estimate: Unchanged at approximately NT$36.73 per share, indicating no material revision in the intrinsic value assessment.
Actualización del análisis Nov 29

2352: Lower Profit Margins Will Give Way To Future Share Price Upside

Analysts have slightly revised their price target for Qisda downward from $37.80 to $36.73. This change is attributed to moderate adjustments to profit margin expectations and future earnings estimates.
Actualización del análisis Nov 15

2352: Earnings Strength and Higher Margins Will Support Upcoming Share Upside

Narrative Update: Qisda Analyst Price Target Revised Analysts have raised their price target for Qisda, increasing it from $37.80 to $37.80. This revision is based on slightly higher expected revenue growth and profit margins, along with a modest uptick in the discount rate and projected future price-to-earnings ratio.
Actualización del análisis Nov 01

2352: Investments In AIoT And Medical Services Will Boost Future Profitability

Qisda Analyst Price Target Updated Analysts have made a minor adjustment to Qisda’s price target, keeping it steady at $37.80. Recent analysis indicates only incremental changes to underlying valuation metrics.
Actualización del análisis Oct 17

Investments In AIoT And Medical Services Will Boost Future Profitability

Analysts have maintained their price target for Qisda at $37.80, citing stable financial indicators and minimal changes to key valuation metrics as supporting rationale for holding their previous outlook. Valuation Changes Fair Value: Remained unchanged at NT$37.80.
Actualización del análisis Oct 03

Investments In AIoT And Medical Services Will Boost Future Profitability

Analysts have raised their price target for Qisda from $31 to approximately $37.80, citing an adjusted fair value estimate. Other core financial projections remain consistent.
Actualización del análisis Sep 17

Investments In AIoT And Medical Services Will Boost Future Profitability

The notable downward revision in Qisda’s consensus analyst price target is primarily driven by a significant decline in net profit margin and a slight decrease in future P/E, lowering fair value from NT$35.75 to NT$31.00. Valuation Changes Summary of Valuation Changes for Qisda The Consensus Analyst Price Target has significantly fallen from NT$35.75 to NT$31.00.
Actualización del análisis Sep 02

Investments In AIoT And Medical Services Will Boost Future Profitability

Qisda’s higher consensus price target reflects a sharp increase in its expected future P/E ratio, signaling improved earnings growth prospects or investor confidence, raising fair value from NT$28.50 to NT$35.75. Valuation Changes Summary of Valuation Changes for Qisda The Consensus Analyst Price Target has significantly risen from NT$28.50 to NT$35.75.
User avatar
Nuevo análisis Feb 21

Investments In AIoT And Medical Services Will Boost Future Profitability

Qisda’s focus on AIoT and AI technologies may increase revenue streams and improve gross margins through innovation in smart automation solutions.
Artículo de análisis Mar 12

Qisda's (TWSE:2352) Weak Earnings May Only Reveal A Part Of The Whole Picture

The market wasn't impressed with the soft earnings from Qisda Corporation ( TWSE:2352 ) recently. We did some further...
Artículo de análisis Mar 09

Qisda Corporation Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next

Qisda Corporation ( TWSE:2352 ) shareholders are probably feeling a little disappointed, since its shares fell 6.9% to...
Artículo de análisis Feb 29

Qisda (TWSE:2352) Takes On Some Risk With Its Use Of Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Artículo de análisis Mar 15

Is Qisda Corporation (TPE:2352) A Smart Pick For Income Investors?

Dividend paying stocks like Qisda Corporation ( TPE:2352 ) tend to be popular with investors, and for good reason...
Artículo de análisis Feb 26

Qisda Corporation's (TPE:2352) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Qisda's (TPE:2352) stock is up by a considerable 32% over the past three months. However, we decided to pay attention...
Artículo de análisis Feb 08

These 4 Measures Indicate That Qisda (TPE:2352) Is Using Debt Reasonably Well

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Artículo de análisis Jan 24

Should You Use Qisda's (TPE:2352) Statutory Earnings To Analyse It?

It might be old fashioned, but we really like to invest in companies that make a profit, each and every year. That...
Artículo de análisis Jan 09

Qisda (TPE:2352) Has Gifted Shareholders With A Fantastic 275% Total Return On Their Investment

When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...

Desglose de ingresos y gastos

Cómo gana y gasta dinero Qisda. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

TWSE:2352 Ingresos, gastos y beneficios (TWD Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
31 Mar 26209,69997725,0087,095
31 Dec 25207,9051,14324,8416,989
30 Sep 25209,8441,28124,3056,918
30 Jun 25208,1052,08323,5136,920
31 Mar 25204,4992,39022,8716,830
31 Dec 24201,6662,16422,0116,651
30 Sep 24198,2332,39921,6406,683
30 Jun 24197,8092,54821,3956,688
31 Mar 24200,0632,90921,1966,807
31 Dec 23203,5952,97621,1216,944
30 Sep 23209,0452,92221,0786,937
30 Jun 23218,7348,08421,5447,305
31 Mar 23229,4178,04221,5517,254
31 Dec 22239,8378,25221,5177,192
30 Sep 22245,5938,87621,0827,065
30 Jun 22242,7343,90720,1646,456
31 Mar 22235,9236,73019,5936,370
31 Dec 21225,9618,30818,9356,260
30 Sep 21221,2239,07318,3376,191
30 Jun 21215,7169,72417,6226,006
31 Mar 21203,4056,86816,3355,434
31 Dec 20191,7024,98815,2934,921
30 Sep 20180,4303,86114,3344,346
30 Jun 20171,5392,82513,5684,009
31 Mar 20169,1012,91813,2303,943
31 Dec 19169,7543,57512,9253,896
30 Sep 19166,2793,98112,2663,851
30 Jun 19163,1484,16611,7713,829
31 Mar 19159,9833,92711,4213,693
31 Dec 18155,7834,03511,0053,711
30 Sep 18150,5164,41210,7143,685
30 Jun 18146,0014,49710,3243,615
31 Mar 18140,8305,0589,8543,671
31 Dec 17136,8625,2919,3033,566
30 Sep 17134,0255,4758,8203,540
30 Jun 17130,8535,6268,4823,443
31 Mar 17129,4765,0598,1813,328
31 Dec 16129,5544,3428,1713,305
30 Sep 16129,4842,9988,1353,341
30 Jun 16130,7502,1418,1273,369
31 Mar 16132,4392,0638,3883,425
31 Dec 15133,1022,1698,5743,469
30 Sep 15134,3232,7278,9193,389
30 Jun 15135,9743,1949,0813,341

Ingresos de calidad: 2352 tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio(0.5%) de 2352 son inferiores a los del año pasado (1.2%).


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de 2352 han disminuido en un 36% al año en los últimos 5 años.

Acelerando crecimiento: 2352 ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: 2352 tuvo un crecimiento negativo de los beneficios (-59.1%) durante el año pasado, lo que dificulta la comparación con la media de la industria Tech (-3.1%).


Rentabilidad financiera

Alta ROE: La rentabilidad financiera de 2352 (1.9%) se considera baja.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/05/09 08:58
Precio de las acciones al final del día2026/05/08 00:00
Beneficios2026/03/31
Ingresos anuales2025/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Qisda Corporation está cubierta por 6 analistas. 1 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Nicholas TeoCLSA
Joey ChengGoldman Sachs
null nullKGI Securities Co. Ltd.